JAGX · Jaguar Health, Inc.
$0.79
-0.02 (-1.85%)
At close · Aug 31
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“While management believes this infusion improves our liquidity, it does not fully alleviate the conditions that raise substantial doubt about our ability to continue as a going concern for one year from the issuance of these financial statements.”View the 10-Q filed Aug 19, 2026
Market Cap
$4.19M
Shares
5.17M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Anula Jayasuriya | Class III director | Appointed | 2022-07-06 |
| Greg J. Divis | member of the Board | Resigned | 2022-07-06 |
| Carol R. Lizak | Chief Financial Officer | Appointed | 2021-04-08 |
| Murray David MacNaughtan | member of the Board | Resigned | 2020-02-27 |
| Jeffery Johnson | member of the Board | Resigned | 2020-02-27 |